Recombinant Human TK2 Protein，His

TK2, or thymidine kinase 2, is a mitochondrial enzyme that plays a crucial role in the salvage pathway of nucleotide metabolism, specifically in the phosphorylation of thymidine to thymidine monophosphate. Research on TK2 has gained significant attention due to its critical involvement in maintaining mitochondrial function and energy production, as well as its implications in various mitochondrial disorders. Mutations in the TK2 gene can lead to a range of myopathies, characterized by muscle weakness, exercise intolerance, and fatigue, often referred to as mitochondrial DNA depletion syndromes. Understanding TK2's structure and function is essential for developing therapeutic strategies for these conditions. Additionally, its potential role in regulating cellular stress responses and apoptosis has opened new avenues in cancer research. Investigating the recombinant expression of TK2 allows for the study of its biochemical and structural properties, facilitating a deeper understanding of its function in health and disease. Moreover, the development of TK2 inhibitors or modulators could lead to novel treatments for diseases linked to mitochondrial dysfunction. Researchers are actively exploring these avenues, employing techniques such as crystallography and molecular dynamics simulations to gain insights into TK2's active site and substrate interactions. Overall, the study of TK2 and its recombinant protein offers significant promise not only for understanding mitochondrial biology but also for developing targeted therapies for a range of diseases associated with mitochondrial dysfunction.